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Abstract: The fatty acid composition of human breast milk is relevant for the energy, immunity and 
eicosanoid production in infants. Additionally, the antioxidant properties of foods are essential for 
human health. Therefore, in the present study we aimed to investigate the relationship between 
maternal diet and fatty acids composition as well as the antioxidant potential of breast milk from 
donors to human milk bank of Perugia’s hospital, Italy. Results were compared with infant 
formulas. We observed increased levels of total fatty acids and, in particular, saturated and 
monounsaturated fatty acids in milk from mothers fed on a vegetable and fruit-rich diet compared 
with a Mediterranean diet. In the same milk, a reduced antioxidant potential was found. All infant 
formulas resulted in richer total fatty acid content than human breast milk. Only some formulas 
were qualitatively similar to breast milk. Of note, the antioxidant potential of the formulas was 
higher or lower than the human milk with the exception of one sample. The antioxidant potential 
of four formulas was very high. Dietary supplementation with antioxidants has been shown to have 
a teratogenic effect and to increase the formation of metastases in adult. There are no data on the 
effects of excess antioxidants in the infants, but the possibility that they can be harmful cannot be 
excluded. 
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1. Introduction 
The lipids in human milk are organized as fat globules or droplets that are secreted by mammary 
epithelial cells. They include especially triglycerides, but also phospholipids, sphingolipids and 
cholesterol esters—all containing fatty acids (FAs). It is generally known to the scientific community 
that FAs can be distinguished as saturated (SFAs) or unsaturated fatty acids (USFAs). The latter can 
be monounsaturated fatty acids (MUFAs, one double bond in carbon chain) and polyunsaturated 
fatty acids (PUFAs, more than one double bond in carbon chain). Moreover, FAs are divided into 
four classes based on the length of the monocarboxylic chain: short-chain FAs (4 carbon atoms) useful 
as growth factors, medium-chain FAs (6–12 carbon atoms) available as energy source, long-chain FA 
(14–18 carbon atoms) useful as source of energy is they are SFAs and as molecules involved in 
fundamental metabolic processes of the cells if they are USFAs, and very long-chain FAs that act as 
functional molecules of biologic membranes with the role in cell fate (20–36 carbon atoms) [1]. In 
milk, short-chain FAs are responsible for its typical flavor; medium-chain FAs are important for its 
functional properties [2]. Human breast milk (HBM) contains—in addition to short and medium-
chain FAs—long- and very long-chain FAs, especially arachidonic acid (ARA, 20:4n-6) and 
docosahexaenoic acid (DHA, 22:6n-3) [3]. The FAs of HBM provide energy and immunity, induce 
eicosanoid production and are used for body structure [4]. Thus, FAs are important for the 
physiology of development.  
It is of interest that a large variation of FA content in HBM is present across different populations, 
especially due to the total amount and quality of fat intake of pregnant and lactating mothers [5]. 
Nutritional errors during the last period of pregnancy and during breastfeeding induce changes in 
the composition of HBM, usually considered the optimum feeding regime for newborn infants [6]. In 
fact, HBM allows complete nutrition including bioactive health factors and its change may affect the 
physiological development of infants [7]. Moreover, HBM can be considered a living liquid able to 
mature and change over time, based on biologic and psychological needs of infants. Thus, milk 
produced in the first 72 h after childbirth or colostrum is transformed into transition milk and then 
into mature milk with the change in the content of water, proteins, lipids, vitamins and minerals. The 
macro- [8] and micronutrient [9,10] composition of milk is closely related to the maternal body 
composition and therefore to her feeding during pregnancy. The FA composition of HBM depends 
on the physiological status of the mother, maternal diet, endogenous biosynthesis in the mammary 
gland, and on the fat deposits of the mothers from which the FAs are released [11]. In milk, changes 
in FAs composition are usually used to highlight its oxidative stability [12] and, in particular, the 
level of USFAs [13]. In fact, their loss is connected with the peroxide value [14]. In accelerated 
oxidation, FAs are broken down to oxidation products which lead to the development of rancid flavor 
with the change for milk quality [15]. Notably, milk contains antioxidants distinguished in two 
categories, fat soluble and water-soluble antioxidants [16]. The first, include vitamin A, E and 
carotenoids and the second casein, vitamin C, cysteine, valine, lactase, glutathione peroxidase and 
superoxide dismutase, zinc and selenium [17]. It is relevant that milk antioxidant properties are 
species-specific [18]. Therefore, breastfeeding provides optimal antioxidant food for neonates [19]. 
Few studies have been conducted on the antioxidant capacity of HBM and on its comparison 
with infant formulas (IFs), used as substitutes of HBM when it is not available [20–24]. All findings 
above reported indicate the essential role of FAs and of antioxidant properties of HBM, but there are 
no studies that highlight, at the same time, the variations of the different parameters. Therefore, in 
the present study, we aimed to investigate: 1) the influence of diet on fatty-acid composition and 
antioxidant potential of breast milk; 2) the comparison between fatty-acid composition and 
antioxidant potential of infant formulas and those of breast milk. In this regard, milks formulated for 
preterm and term infants compared to milks of mothers with preterm and term birth were analyzed. 
These data are relevant because the composition of milk is different in relation to the gestational age 
[11] and because preterm infants have different nutritional needs in comparison with term infants. 
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2. Results 
2.1. Mothers and Infants 
It was reported that HBM composition depends on endogenous biosynthesis of molecules in the 
mammary gland, mother’s body mass index (BMI), physiological and nutritional status, gestational 
age at birth, diet and breed [5,9–11]. In order to further understand the relationships among different 
factors, we performed a study on milk from donor mothers in Umbria, Italy. For the study, we first 
analyzed parameters of mothers and infants with an interview. The exclusion criteria were: 1) 
mothers with a history of pathology; b) mothers who use drug, alcohol and smoke. The inclusion 
criteria were: 1) the BMI > 25 and BMI < 25 at the beginning of pregnancy; 3) physical activity carried 
out or not before and after pregnancy; 4) preterm birth (PT) and term birth (T). Thirty mothers aged 
32.32 ± 4.89 were studied. The analysis of the interview indicated that of 30 considered mothers, 8 
had a BMI > 25 at the beginning of pregnancy. The increase in weight during pregnancy was not 
related to the BMI (11.5 ± 3.4 kg for BMI > 25 and 12.50 ± 4.1 kg for BMI < 25). Only 4 mothers did 
physical activity during pregnancy (all belonged to a group with BMI < 25) and the increase in weight 
was moderately, but not highly significant related with it (10.5 ± 1.8 kg against 12.41 ± 3.8 kg for BMI 
< 25). Of note, the weight of infants was independent on the BMI of mothers (1.6 ± 3.1 kg for PT birth 
and 3.4 ± 4.1 kg for T birth in mothers with BMI > 25 and 1.52 ± 4.0 kg for PT birth and 3.3 ± 3.6 kg for 
T birth in mothers with BMI < 25). In addition, the diet did not influence in significant manner the 
weight of mothers during pregnancy and of infants at the birth. Different diets were considered: 1) 
Mediterranean diet (MD); diet rich in vegetables and fruit and with very low content of meat, fish, 
eggs and cereals (VF); diet rich in meat and fish with very low content of eggs, vegetables and fruit 
(MF); diet rich in meat and cereals with very low content of eggs, meat, vegetables and fruit (MC). 
Results showed that 18 mothers followed MD, 4 mothers followed VF diet, 4 mothers followed MF 
diet, and 4 mothers followed MC diet. The age of mothers was 31.66 ± 5.1 years for MD, 35.00 ± 1.26 
years for VF, 33.2 ± 3.00 years for MF, 30.75 ± 3.27 years for MC diets. The increase in the weight of 
mothers during pregnancy was 13.33 ± 4.38 kg, 11.00 ± 2.34 kg, 11.6 ± 2.41 and 11.02 ± 3.74 with MD, 
VF, MF and MC diet, respectively. The age of mothers with PT was 32.12 ± 3.29 years and that of 
mothers with T was 31.71 ± 4.50. The weight of infants was 3.61 ± 0.39 kg, 3.41 ± 0.25 kg, 3.32 ± 0.64 
kg and 3.09 ± 4.4 in T birth with MD, VF, MF and MC maternal diet, respectively. The PT infants from 
mothers fed on MD were 6 and weighted 1.77 ± 0.25 kg; none PT infant was from mothers fed on VF; 
1 PT infant was from mothers fed on MD and weighted 1.95 kg; 1 PT infant was from mothers fed on 
MC and weighted 1.55 kg. Therefore, the type of diet is not relevant for the weight increase of mothers 
during pregnancy and for the weight of infants at the birth. 
2.2. Fatty Acid Composition of Human Breast Milk and Infant Formulas 
First, we set out to measure FA composition of HBM of mothers fed on MD, VF, MF and MC 
diet in order to highlight, with accurate statistical analysis, the specific role of the diet. We considered 
the general similarity or difference of total FAs and SFAs–MUFAs–PUFAs in milk of mothers fed on 
VF, MF and MC diet in comparison with milk of mothers fed on MD) and then specific similarity or 
difference of each SFA–MUFA–PUFA species. Thus, MD was empirically used as comparison diet 
because it was used by most mothers. Intriguingly, the results showed that only VF diet impacted 
HBM FA composition. In fact, total FAs increased (Figure 1a) especially SFAs and MUFAs content 
(Figure 1b). Among SFA, short-chain, medium and long FAs increased significantly. Notably, 
palmitic acid (C18:0) increased in highly significant manner (Figure 1c). Among MUFAs, there were 
a specific increase of oleic acid (C18:1n9) and a reduction of other FAs (Figure 1d), so that the total 
MUFAs unchanged (Figure 1b). 
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Figure 1. Fatty acid composition in human breast milk of mothers fed on different diets during 
pregnancy. MD, Mediterranean diet; VF, diet rich in vegetables and fruit and with very low content 
of meat, fish, eggs and cereals; MF, diet rich in meat and fish with very low content of eggs, vegetables 
and fruit; MC, diet rich in meat and cereals with very low content of eggs, meat, vegetables and fruit. 
a) total fatty acids (FA); b) Saturated fatty acids (SFA), monounsaturated fatty acids( MUFA) and 
polyunsaturated fatty acids (PUFA); c) species of SFA; d) species of MUFA. Data are expressed as 
mean ± SD calculated as reported in “Statistical analysis”. Significance of VF, MF, MC versus MD: *p 
< 0.05; **p < 0.01; ***p < 0.001. 
Among PUFAs only DPH was highly reduced with VF. The reduction of total PUFAs with MC 
diet (Figure 1b) was due to the low level of n-6 PUFA (Figure 2a), specifically of linoleic acid (Figure 
2c) with consequently lower level of n-6 PUFA/n-3 PUFA ratio (Figure 2d). 
 
Figure 2. Polyunsaturated fatty acid composition in human breast milk of mothers fed on different 
diets during pregnancy. MD, Mediterranean diet; VF, diet rich in vegetables and fruit and with very 
low content of meat, fish, eggs and cereals; MF, diet rich in meat and fish with very low content of 
eggs, vegetables and fruit; MC, diet rich in meat and cereals with very low content of eggs, meat, 
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vegetables and fruit. a) total n-3 PUFA and n-6 PUFA; b) species of n-3 PUFA: alfa-linolenic acid, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); c) species of n-6 PUFA: linoleic acid, 
dihomo-gamma-linolenic acid, arachidonic acid (ARA), docosatetraenoic acid (DTA), 
docosapentaenoic acid (DPA); d) n-6 PUFA/n-3 PUFA ratio. Data are expressed as mean ± SD 
calculated as reported in “Statistical analysis”. Significance of VF, MF, MC versus MD: *p < 0.05; **p < 
0.01; ***p < 0.001. 
It then became important to determine whether FA composition of IFs was similar to the HBM 
of mothers fed on MD. Considering that on the market there are IFs for preterm (PT) and term (T) 
babies as these have different nutritional needs, to increase the power of comparisons, data of HBM 
from mothers fed on MD were grouped in PT and T. The rationale is that it is important to know the 
differences between IFs and HBM because it is good that IFs are as close as possible to HBM. 
As can be seen, milk of T mothers had a lower level of total FAs (Figure 3a) in comparison with 
milk of PT mothers, due to the lower level of both SFAs and PUFAs (Figure 3b). All analyzed SFA 
species showed reduced values (Figure 3c). No important variations of MUFA were found (Figure 
3c). 
 
Figure 3. Fatty acid composition in human breast milk of mothers fed on Mediterranean diet with 
preterm birth (PT) and term birth (T). a) total fatty acids (FA); b) Saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA); c) species of SFA; d) 
species of MUFA. Data are expressed as mean ± SD calculated as reported in “Statistical analysis”. 
Significance of T versus PT: *p < 0.05; **p < 0.01; ***p < 0.001. 
Among n-3 PUFA, you can see a reduction of alfa-linoleic acid and an increase of EPA (Figure 
4b) that together did not change the total level of n-3 PUFA (Figure 4a). Differently, n-6 PUFA was 
moderately reduced because of the lower level of linoleic acid (Figure 4c). 
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Figure 4. Polyunsaturated fatty acid composition in human breast milk of mothers fed on 
Mediterranean diet with preterm birth (PT) and term birth (T). a) total n-3 PUFA and n-6 PUFA; b) 
species of n-3 PUFA: alfa-linolenic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA); c) species of n-6 PUFA: linoleic acid, dihomo-gamma-linolenic acid, arachidonic acid (ARA), 
docosatetraenoic acid (DTA), docosapentaenoic acid (DPA); d) n-6 PUFA/n-3 PUFA ratio. Data are 
expressed as mean ± SD calculated as reported in “Statistical analysis”. Significance of T versus PT: 
*p < 0.05; **p < 0.01; ***p < 0.001. 
Thus, we analyzed separately 5 IF used for PT neonates and 5 IF used for T neonates and 
compared the results with PT and T HBM, respectively. As can be seen, all PT formulas had a very 
higher content of total FAs than PT HBM, in particular IF 2 and 3 (Figure 5a). The IF 1 and 2 were 
very highly richer in SFAs and milk 3 in MUFAs; formula 5 was that most similar to HBM (Figure 
5b). Formula 2 was rich in short, medium and long chain FAs (Figure 5c) and formula 4 in oleic acid 
(C18:1n9) (Figure 5d). 
 
Figure 5. Fatty acid composition in human breast milk of mothers with preterm birth fed on 
Mediterranean diet (MD–PT) during pregnancy and in 5 infant formulas used to feed preterm birth 
Molecules 2020, 25, 2910 7 of 18 
 
infants. a) total fatty acids (FA); b) Saturated fatty acids (SFA), monounsaturated fatty acids (MUFA) 
and polyunsaturated fatty acids (PUFA); c) species of SFA; d) species of MUFA. Data are expressed 
as mean ± SD calculated as reported in “Statistical analysis”. Significance of 1PT, 2PT, 3PT, 4PT and 
5PT versus MD–PT: *p < 0.05; **p < 0.01; ***p < 0.001. 
All formulas were rich in n-3 PUFA (Figure 6a) and, in particular, in alfa-linolenic acid and DHA 
content, with the exception of formula 1(Figure 6b). Furthermore, n-6 PUFA had a high value, in 
particular in formulas 1 and 3 (Figure 6a) due to high level of linoleic and ARA content (Figure 6d). 
However, the high level of n-3 PUFA was responsible for the lower value of omega6/omega3 ratio in 
formulas respect to HBM. 
 
Figure 6. Polyunsaturated fatty acid composition in human breast milk of mothers with preterm birth 
fed on Mediterranean diet (MD–PT) during pregnancy and in infant formulas used to feed preterm 
birth infants a) total n-3 PUFA and n-6 PUFA; b) species of n-3 PUFA: alfa-linolenic acid, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); c) species of n-6 PUFA: linoleic acid, 
dihomo-gamma-linolenic acid, arachidonic acid (ARA), docosatetraenoic acid (DTA), 
docosapentaenoic acid (DPA); d) n-6 PUFA/n-3 PUFA ratio. Data are expressed as mean ± SD 
calculated as reported in “Statistical analysis”. Significance of 1PT, 2PT, 3PT, 4PT and 5PT versus MD–
PT: *p < 0.05; **p < 0.01; ***p < 0.001. 
The IF for T infants were all richer in total FAs than T HBM with the exception of formula 2 that 
is poorer (Figure 7a), due to the content of SFAs, MUFAs and PUFAs, (Figure 7b), each class rich in 
all its components (Figure 7c,d). 
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Figure 7. Fatty acid composition in human breast milk of mothers with term birth fed on 
Mediterranean diet (MD-T) during pregnancy and in 5 infant formulas used to feed term birth infants. 
a) total fatty acids (FA); b) Saturated fatty acids (SFA), monounsaturated fatty acids(MUFA) and 
polyunsaturated fatty acids (PUFA); c) species of SFA; d) species of MUFA. Data are expressed as 
mean ± SD calculated as reported in “Statistical analysis”. Significance of 1T, 2T, 3T, 4T and 5T versus 
MD-T: *p < 0.05; **p < 0.01; ***p < 0.001. 
The same IFs had a higher total content of n-3 PUFA (Figure 8a) with higher level of alfa-linolenic 
and DHA and lower level of EPA (Figure 8b). Despite the increase of total and of each species of n-6 
PUFA (Figure 8a,c), n-3 PUFA were prevalent so that the n-6 PUFA/n-3 PUFA ratio was lower than 
that present in T HBM (Figure 8d). 
 
Figure 8. Polyunsaturated fatty acid composition in human breast milk of mothers with term birth 
fed on Mediterranean diet (MD-T) during pregnancy and in infant formulas used to feed term birth 
infants a) total n-3 PUFA and n-6 PUFA; b) species of n-3 PUFA: alfa-linolenic acid, eicosapentaenoic 
Molecules 2020, 25, 2910 9 of 18 
 
acid (EPA) and docosahexaenoic acid (DHA); c) species of n-6 PUFA: linoleic acid, dihomo-gamma-
linolenic acid, arachidonic acid (ARA), docosatetraenoic acid (DTA), docosapentaenoic acid (DPA); 
d) n-6 PUFA/n-3 PUFA ratio. Data are expressed as mean ± SD calculated as reported in “Statistical 
analysis”. Significance of 1T, 2T, 3T, 4T and 5T versus MD-T: *p < 0.05; **p < 0.01; ***p < 0.001. 
2.3. Antioxidant Potential Of Human Breast Milk and Infant Formulas 
To further investigate the influence of diet on HBM as good food, we next analyzed its 
antioxidant potential. As shown in Figure 9a, VF diet was responsible for a reduction of antioxidant 
potential value in comparison with milk from mothers fed on MD and the contrary was obtained 
with MF and MC diet. PT and T birth did not influence the antioxidant potential of milk from mothers 
fed on MD (Figure 9b). 
 
Figure 9. Antioxidant potential of human breast milk. a) milk samples of mothers fed on different 
diets during pregnancy. MD, Mediterranean diet; VF, diet rich in vegetables and fruit and with very 
low content of meat, fish, eggs and cereals; MF, diet rich in meat and fish with very low content of 
eggs, vegetables and fruit; MC, diet rich in meat and cereals with very low content of eggs, meat, 
vegetables and fruit; b) milk samples of mothers fed on Mediterranean diet during pregnancy with 
preterm birth (PB) and term birth (TB). Data are expressed as mean ± SD calculated as reported in 
“Statistical analysis”. Significance of VF, MF, MC versus MD: ***p < 0.001. 
PT IF had all values different from respective HBM; in particular, formulas 2, 3 and 4 were 2.6, 
2.1 and 1.7 times higher (Figure 10a). Among T IF, only formula 5 had a value similar to that of T 
HBM and formula 3 was 5 times higher (Figure 10b). 
*** 
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Figure 10. Comparison of antioxidant potential of human breast milk and infant formulas. a) human 
breast milk of mothers with preterm birth (PT) fed on Mediterranean diet during pregnancy and in 
infant formulas used to feed preterm birth infants; b) human breast milk of mothers with term birth 
(T) fed on Mediterranean diet during pregnancy and in infant formulas used to feed term birth infants. 
Data are expressed as mean ± SD calculated as reported in “Statistical analysis”. Significance of 1PT, 
2PT, 3PT, 4PT and 5PT versus MD–PT and of 1 T, 2 T, 3 T, 4 T and 5 T versus MD-T: *p < 0.05; **p < 
0.01; ***p < 0.001. 
3. Discussion 
Major revelations from this study are that: 1) VF diet is responsible for a high content of SFAs 
and MUFAs and a low antioxidant potential of HBM; 2) mothers fed on MD produced a milk rich in 
SFAs and PUFAs without changes of antioxidant potential if the infant was PT birth respect to T birth; 
3) IFs are highly variable in the composition of FAs both from each other and from breast milk with 
truly significant variations in the antioxidant potential. 
3.1. Relevance of Fatty Acids in Human Breast Milk 
To date, research has established the importance of FA species for the nutritional characteristics 
of milk. FAs composition of HBM depends on many factors, as endogenous biosynthesis in the 
mammary gland, fat deposits of the mothers, gene predisposition and maternal diet [5,11]. We 
focused the attention on maternal diet because it is a modular factor. Moreover, it has been 
demonstrated that nutritional errors during the last period of pregnancy and during breastfeeding 
induce changes in the composition of HBM [6]. Since the foods introduced by mothers with the diet 
contain many macro- and micronutrients, it is really difficult to establish exactly which nutrients 
interfere with the lipid metabolism of the mammary gland. Our study shows that certainly the FA 
composition of HBM varied with VF, MF and MC diets towards MD. Yuan et al. [25] highlighted that 
lipid aggregates of HBM present at the end of gastric digestion become smaller and then resolve in 
two hours in intestinal digestion, while IFs present a more large number of aggregates that slow lipid 
digestion. Therefore, differences in lipid absorption are present between HBM and IFs. The fat 
aggregates are absent in vegetable oils [4]. Among FAs, SFAs are considered of lower value than 
a) 
a) 
a) 
b) 
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PUFAs for human health. In fact, PUFAs are metabolically transformed in molecules involved in the 
regulation of different cell functions, the eicosanoids as prostaglandins, leukotrienes, thromboxane, 
resolvins, protectins, maresins [26]. The eicosanoids and endocannabinoids, also produced from 
PUFAs, are essential for the development and functioning of the nervous system [27]. Moreover, 
PUFAs have immunomodulatory properties, essential for the infants. In our study, the high level of 
linoleic and -linolenic acid can be found with any type of diet, suggesting that it is a specific 
characteristic of HBM. Therefore, our data showing an enrichment of PUFAs in the IFs respect to 
HBM may indicate a positive aspect of IFs that may be very useful for the health of the neonates even 
if breastfeeding has been associated with optimal brain development and/or function [28]. Most IFs 
derive from cow milk, but they can be prepared also from vegetable oils. Begner et al. (2020) [29], in 
a pilot study, demonstrated that PT infants fed on exclusive HBM do not show in time severe 
cognitive developmental delay and present favorable growth and body composition. Differently, PT 
infants feed on IF show an increase in adverse outcomes respect to the use of HBM [30]. It is possible 
that it may be due to the presence of other nutrients specific for the brain in HBM. 
3.2. Fatty Acids and Antioxidant Potential Relation in the Milk 
Our data show that VF diet increases SFAs and MUFAs without changes of PUFAs, despite a 
reduced antioxidant potential compared to MD. On the other hand, milk from PT and T mothers have 
a similar antioxidant potential with different content of SFAs and PUFAs. It has been demonstrated 
that preservation of PUFAs, thanks to a good antioxidant potential, contributes to improve the quality 
of the milk [31]. It is possible that the antioxidant potential of HBM relatively influences the 
composition of FAs and in any case, despite being reduced, is capable of protecting PUFAs. Our data 
disagree with Oveisi et al. (2010) [21] who reported that an increased consumption of dairy products, 
fruits and vegetables, cereals and nuts induce an increase of the total antioxidant capacity of the HBM 
[21]. It is true that mothers belonging to our study did not eat cereals and nuts and that the use of 
cereals together to meat (MC diet) increases the antioxidant potential of the milk. In a systematic 
review on HBM from all non-vegetarian, vegetarian and vegan mothers, the nutritional values appear 
all comparable with the exception of FA composition and micro-components [32]. The authors 
observed that the dietary choices cannot be an exclusion criterion for donor candidates in human 
milk banks even if in some countries vegan lactating women as milk donors are excluded. The 
mothers object of this study were not vegetarian or vegan but followed a diet rich in vegetables and 
fruit with very low content of meat, fish, eggs and cereals (VF). Considering the low content of SFAs 
and the high content of vitamins in vegetables and fruit, we would have expected a result opposite 
to that obtained. It is possible that sugars present in these foods are metabolically used to synthesize 
SFAs useful for body energy, considering the low intake of other foods. Moreover, the antioxidant 
potential is low because of vegetable vitamins are lost with cooking, recommended procedure during 
pregnancy. The higher level of antioxidant potential in HBM of mothers fed on MF and MC diet 
suggest that it may be due to polypeptides or proteins, i.e., glutathione, catalase, etc. It is known that 
pasteurization, thermal processes applied for the preservation of milk by reducing/ eliminating the 
bacteria, may impact on its lipid content and antioxidant characteristics [33]. In our study, 
pasteurization was performed either in HBM intended for the milk bank or in cow’s milk used for 
the preparation of IF. In addition, HBM samples were frozen for storage in the milk bank. Since the 
antioxidant potential of HBM is reduced by freezing [19], we supposed that it could occurs also in 
IFs. Thus, we diluted—in accordance with the instructions of the companies—the samples of IF 
powder. Then, we froze the milk to subject it to the same conditions as HBM. Therefore, our analyses 
were direct to know the characteristics of HBM and IF samples that had undergone the same 
treatments. Significant research has been devoted to highlight that PT infants born relatively deficient 
in antioxidant defenses and with increased oxidant stress [23]. Antioxidant capacity of HBM of mothers 
with PT birth is higher than that HBM of mothers T birth [34]. Our results show no variations of 
antioxidant potential in the milk of PT mothers in comparison with T mothers who followed a MD, 
supporting the important role of this kind of the diet for HBM composition. Moreover, it has been 
shown that HBM has better antioxidant capacity than IFs [20,21]. In time, IFs have been changed in 
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relation to the needs of neonates and today their production is a field in constant evolution. Notably, 
antioxidant potential of IFs analyzed in the present study is higher or lower than that of HBM of 
mother fed on MD, with the exception of one sample that has a value very similar to that of HBM. 
The antioxidant potential of 4 formulas is really high, probably due to an enrichment with vitamin or 
others nutrients. It is known that consumption in adults of high level of antioxidants can be harmful 
to health [35]. In fact, it is negatively associated with metabolic syndrome [36], has teratogen effect 
[37] and can increase melanoma metastasis [38]. At the moment, there are no data on the effects of 
antioxidants in infants, but the possibility that they can be harmful to health cannot be excluded. 
4. Materials and Methods 
4.1. Materials 
Anhydrous sodium sulfate, chloroform, hexane, methanol and potassium hydroxide were 
purchased from Carlo Erba Reagents (Milan, Italy). Supelco™ 37 component fatty acid methyl esters 
(FAME) mix, containing the methyl esters of 37 fatty acids was supplied by Supelco (Bellefonte, PA, 
USA). 
4.2. Sample Collection Procedure 
For this study, BLUD (Banca del Latte Umano Donato, Struttura Complessa di Neonatologia e 
Terapia Intensiva Neonatale—Azienda Ospedaliera Santa Maria della Misericordia—Perugia, Italy) 
provided human milk samples from thirty healthy donors. All mothers who had pathologies, such 
as hypo- or hyperthyroidism, diabetes, adrenal diseases, autoimmune diseases and alteration of the 
lipid profile in the blood were excluded. The project was approved by the Bioethics Committee of 
Perugia University (number 2018-05) and all procedures were performed accordingly. All donors 
signed informed consent. The milk samples were collected between March 1, 2019 and September 30, 
2019 by using standardized procedures. Immediately after collecting, milk samples were submitted 
to Holder pasteurization that aims to rid milk of potentially harmful germs by heating it to 62.5 °C 
(145 °F) for half an hour, and then cooling it back down to 4–10 °C, a method used the world over to 
help ensure that the milk distributed by human milk banks is safe for infants to consume. Samples 
were then stored in a −20 °C freezer before analysis in order to know exactly the characteristics of the 
milk used to feed the infants. 
4.3. Mothers Interview 
A specific interview was carried out with the mothers to find out: a) the state of health of the 
pregnant and lactating subject; b) the consumption of drugs, alcohol, smoking during pregnancy and 
during breastfeeding; c) the anthropometric measures pre- and post-pregnancy; d) physical activity 
carried out before and after pregnancy; e) gestational time and weight of the newborn; f) nutritional 
habits of the subject during pregnancy e during breastfeeding. Regarding the diet followed, the 
interview aimed to have information on how many mothers followed a Mediterranean diet (MD), 
how many had eaten mainly vegetables and fruit (VF), how many had eaten mainly meat and fish 
(MF) and, finally, how many had eaten mainly meat and cereals (MC). 
4.4. Lipid Extraction and Gas Chromatographic Analysis of Fatty Acids 
Milk lipid fraction was extracted using a chloroform–methanol mixture (2:1, v/v), following the 
procedure previously reported [39]. The fatty acid methyl esters (FAME) of total lipids were prepared 
by transmethylation with methanolic KOH and analyzed by high-resolution gas chromatography. A 
DANI 1000DPC gas-chromatograph (Norwalk, CT, USA), equipped with a split–splitless injector and 
a flame ionization detector, was used. FAME separation was performed with a CP-Select CB for 
FAME fused silica capillary column (50 m × 0.25 mm i.d., 0.25 μm f.t.; Varian, Superchrom, Milan, 
Italy). The injector and detector temperatures were 250 °C. The oven temperature was 60 °C, held for 
5 min then raised to 225 °C at 3 °C/min; the final temperature was held for 10 min. The 
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chromatograms were acquired and processed using Clarity integration software (DataApex, Ltd., 
Prague, Czech Republic). 
A standard solution containing 37 FAME was used to identify the individual fatty acids. The 
percentage of each FA was calculated using the peak area corrected with the respective correction 
factors [39]. HRGC analysis was carried out in triplicate. 
4.5. Antioxidant Assay by Oxygen Radical Absorbance Capacity (ORAC) 
The antioxidant capacity of umbrian LBB extract was determined using the ORAC method as 
previously reported [40]. We have chosen ORAC method because it is a robust and reliable method. 
In fact, the ORAC assay, other common measures of antioxidant capacity include ferric ion reducing 
antioxidant power and trolox equivalence antioxidant capacity assays and therefore is considered to 
be a preferable method because of its biologic relevance [41]. A duplicate extraction was performed 
for each sample and used to evaluate the lipophilic (L-ORACFL) and hydrophilic ORACFL (H-
ORACFL) values. Evaluations of the lipophilic and hydrophilic ORACFL in the LBBs samples were 
performed separately, and the total antioxidant capacity (TAC) was calculated by adding the L-
ORACFL and H-ORACFL values. The ORACFL assays were carried out on a FLUOstar OPTIMA 
microplate fluorescence reader (BMG LABTECH, Offenburg, Germany) at an excitation wavelength 
of 485 nm and an emission wavelength of 520 nm. The procedure was based on the method of Zulueta 
et al. (2009) with slight modifications. Briefly, 2,20-azobis (2-methylpropionamide) dihydrochloride 
(AAPH) was used as a peroxyl radical generator, trolox was used as a reference antioxidant standard, 
and fluorescein was used as a fluorescent probe. The data are expressed as micromoles of trolox 
equivalents (TE) per gram of sample (μmol TE/g). 
4.6. Statistical Analysis 
We first consider suitable samples of data concerning the concentration of different acids of milk 
samples, and successively the corresponding samples of data concerning the antioxidant potential. 
We used MD samples consisting of that data on a suitable number of patients, which better express 
the goodness of our experimental results. We compute the related mean and standard deviation by 
using Excel. Successively, we consider three other samples, VF, MF and MC, respectively, which 
contain the corresponding data about other smaller groups of patients. We compute again the mean 
and the standard deviation of each sample. Moreover, we called 1PT, 2PT, 3PT, 4PT and 5PT samples 
of preterm formulas from 5 different companies and 1T, 2T, 3T, 4T, and 5T samples of term formulas 
from other 5 different companies, we also get the mean and the standard deviation. We compare with 
the MD samples other HBM samples obtained by our experimental results. Moreover, MD samples 
were divided into preterm HBM (PT) and term HBM (T) samples and T samples were analyzed 
against PT. PT and T infant formulas were analyzed against MD PT and T HBM, respectively. 
Without loss of generality, we may assume that the total world population of nursing mothers has a 
“normal” distribution, and that the chosen samples are pairwise independent. Since the number of 
patients of each sample is less than 30 and, in general, the variances of the samples are not equal, 
we deal with Welch’s  -test [42]. When we compare two samples    and   , this test defines the 
statistic    by means of the formula where     is the size,     is the mean and     is the standard 
deviation of   ,   = 1,2 and in general    ≠   . 
  =
   −   
 
  
 
  
 ±  
  
 
  
 , 
(1) 
We will test the null hypothesis    =    (  ) versus the alternative hypothesis    ≠    (  ), 
where     and     are the means corresponding to the world nursing mothers populations in 
connection with the considered milk antioxidant powers or acid concentrations, related to    and 
  , respectively. The studied test statistic is: 
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  =
   −    − (   −   )
 
  
 
  
 ± 
  
 
  
 . 
(2) 
In considering artificial milks, when the mean and the variance of the corresponding    are 
given, it is not necessary to know all elements of   , because    = 3: indeed, by the definition of 
mean and sample standard deviation,    and    are equal to the mean and the standard deviation, 
respectively, of the sample    = {   −   ,   ,     ±   }, Thus, in this case, without restriction, in our 
calculations we “replace”    with   . 
The Excel functions T.TEST and TEST.T compute directly the p-value related to  , that is the 
quantity 
2 ⋅ min {   ({  ≤  |  }),    ({  ≥  |  })}, (3) 
where the symbols in (3) denote the probability that the test statistic   is less (resp. greater) than or 
equal to  , when the null hypothesis    is true since we deal with a two-tail hypothesis test. The  -
value is the smallest significance level at which the obtained data lead to reject the null hypothesis. 
As we consider the significance levels    = 0.05,    = 0.01 or    = 0.001, the null hypothesis will 
be rejected if and only if the  -value is less than or equal to    (or    or   ). Thus, a  -value   ≤    
(or   ≤    or   ≤   ) indicates that the sample    is significant (resp. highly significant, strongly 
significant) with respect to    or equivalently that    is significant (resp. highly significant, strongly 
significant) with respect to   . 
When we compare our “white” sample    with the corresponding sample    related with an 
artificial milk, if we have the mean, but not the variance of   , we consider the statistic  ̃ defined by 
 ̃ =
(   −   ) √  
  
 , (4) 
where    and    are the size and the standard deviation of   , respectively and    is the mean of 
  ,   = 1,2. The associated test statistic is 
   =
(   −   ) √  
  
 , (5) 
where   ,   ,    and    have the same meaning as above. We will test the null hypothesis    =    
versus the alternative hypothesis    ≠   . The variable     is a “Student-type”   random variable 
with    − 1 degrees of freedom. The Excel functions TDIST and DISTRIB.T compute the related  -
value. Note that in this case, if we do the hypothesis that    has null variance, then considering   
(resp.  ) is equivalent to dealing with  ̃ (resp.   ) and the involved statistic is independent of the 
size of   . 
Now, let    be the first “white sample” on the antioxidant power of the considered milks and 
let  ,  ,   denote its size, mean and standard deviation, respectively. We compute a 95, a 99 and a 
99,9 percent confidence interval estimator for the mean   of the total world population of nursing 
mothers. Since the variance    of this population is unknown and the size of    is less than 30, it is 
advisable to replace    with its estimator   , and to deal with the random variable 
     =
(  −  ) √ 
 
 , (6) 
which is a “Student-type”   random variable with   − 1 degrees of freedom. Let us consider the 
probability density       associated with       and let     ,    be the real number such that 
  ({     >     ,  }) =   ,   = 1,2,3. Since the graph of      is symmetric with respect to the  -axis, 
we get 
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1 −    =   ({|    | ≤     ,  / }) =      
|  −  | √ 
 
≤     ,  /    = 
=        −     ,  /   
 
√ 
≤   ≤    ±     ,  /   
 
√ 
  . 
(7) 
Thus, a 100(1 −   ) percent confidence interval estimator for the mean   of the considered 
population is given by 
   ±      ,  /   
 
√ 
 , (8) 
that is [43]. 
   −     ,  /   
 
√ 
,     ±      ,  /   
 
√ 
  (9) 
The computation of this interval is done by using Excel again. When we compare two samples 
  ,    and we get only the size, the mean and the standard deviation of the samples without having 
the complete data, like for instance in the case of the acids  ,  ,  , etc., it is not possible to use 
directly the Excel functions T.TEST or TEST.T. Therefore, in Welch’s test, we first compute the 
number of the degrees of freedom   by means of the formula (formula 26) [41] and then we round 
  to the nearest integer. The Excel functions TDIST and DISTRIB.T compute the corresponding  -
value. 
  =
 
  
 
  
 ±  
  
 
  
 
 
  
 
  
 (   − 1)
 ±  
  
 
  
 (   − 1)
 (10) 
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Abbreviations 
ARA arachidonic acid 
BMI body mass index 
DHA docosahexaenoic acid 
DPA docosapentaenoic acid 
DTA docosatetraenoic acid 
EPA eicosapentaenoic acid 
FAs fatty acids 
HBM human breast milk 
IF infant formulas 
MC diet rich in meat and cereals with very low content of eggs, meat, vegetables and fruit 
MD Mediterranean diet 
MF diet rich in meat and fish with very low content of eggs, vegetables and fruit 
MUFAs monounsaturated fatty acids 
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PT preterm birth 
PUFAs polyunsaturated fatty acids 
SFAs saturated fatty acids 
T term birth 
USFAs unsaturated fatty acids 
VF diet rich in vegetables and fruit and with very low content of meat, fish, eggs and cereals 
References 
1. Agostoni, C.; Bruzzese, M.G. Fatty acids: Their biochemical and functional classification. Pediatr. Med. Chir. 
1992, 14, 473–479. 
2. Nadeem, M.; Situ, C.; Abdullah, M. Effect of olein fractions of milk fat on oxidative stability of ice cream. 
Int. J. Food Prop. 2015, 18, 735–745. 
3. Koletzko, B. Human Milk Lipids. Ann. Nutr. Metab. 2016, 69, 28–40. 
4. Bobiński, R.; Bobińska, J. Fatty acids of human milk—A review. Int. J. Vitam. Nutr. Res. 2020, 21, 1–12. 
doi:10.1024/0300-9831/a000651. 
5. Bahreynian, M.; Feizi, A.; Kelishadi, R. Is fatty acid composition of breast milk different in various 
populations? A systematic review and meta-analysis. Int. J. Food Sci. Nutr. 2020, 7, 1–12. 
6. Walker, A. Breast Milk as the Gold Standard for Protective Nutrients. J. Pediatr., 2010, 156, S3–S7. 
7. Agostoni, C.; Braegger, C.; Decsi, T.; Kolacek, S.; Koletzko, B.; Michaelsen, K.F.; Mihatsch, W.; Moreno, 
L.A.; Puntis, J.; Shamir, R.; et al. Breast-feeding: A commentary by the ESPGHAN Committee on Nutrition. 
ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 112–125. 
8. Leghi, G.E.; Middleton, P.F.; Netting, M.J.; Wlodek, M.E.; Geddes, D.T.; Muhlhausler, B.S. A Systematic 
Review of Collection and Analysis of Human Milk for Macronutrient Composition. J. Nutr. 2020, 150, 1652–
1670.  
9. Hampel, D.; Dror, D.K.; Allen, L.H. Micronutrients in Human Milk: Analytical Methods. Adv. Nutr. 2018, 
9, 313S–331S. 
10. Whitfield, K.C.; Shahab-Ferdows, S.; Kroeun, H.; Sophonneary, P.; Green, T.J.; Allen, L.H.; Hampel, D. 
Macro- and Micronutrients in Milk from Healthy Cambodian Mothers: Status and Interrelations. J. Nutr. 
2020, 150, 1461–1469. 
11. Jensen, R.G. Lipids in human milk. Lipids 1999, 34, 1243–1271. 
12. Gulla, S.; Waghray, K. Effect of storage on physicochemical characteristics and fatty acid composition of 
selected oil blends. J. Lipid Sci. 2011, 3, 35–46. 
13. Datta, N.; Deeth, H.C. UHT and aseptic processing of milk and milk products. In Advances in Thermal and 
Non-Thermal Food Preservation; Tewari, G., Juneja, V.K., Eds.; Wiley: Hoboken, NJ, USA, 2007; pp. 63–90. 
14. Ajmal, M.; Nadeem, M.; Imran, M.; Mushtaq, Z.; Ahmad, M.H.; Tayyab, M.; Kamran Khan, M.; Gulzar, N. 
Changes in fatty acids composition, antioxidant potential and induction period of UHT-treated tea 
whitener, milk and dairy drink. Lipids Health Dis. 2019, 18, 213. 
15. Nadeem, M.; Ullah, R. Improvement of the physical and oxidative stability characteristics of ice cream 
through interesterified Moringa oleifera oil. Pak. J. Sci. Ind. Res. Ser. B Biol. Sci. 2016, 59, 38–43. 
16. Lindmark-Mansson, H.; Akesson, B. Antioxidative factors in milk. Br. J. Nutr. 2000, 84, 103–110. 
17. Richmond, H.D. Dairy Chemistry: A Practical Handbook for Dairy Chemists and Others Having Control 
of Dairies. Nature 1914, 94, 249. 
18. Vázquez, C.V.; Rojas, M.G.; Ramírez, C.A.; Chávez-Servín, J.L.; García-Gasca, T.; Ferriz Martínez, R.A.; 
García, O.P.; Rosado, J.L.; López-Sabater, C.M.; Castellote, A.I.; et al. Total phenolic compounds in milk 
from different species. Design of an extraction technique for quantification using the Folin-Ciocalteu 
method. Food Chem. 2015, 176, 480–286. 
19. Păduraru, L.; Dimitriu, D.C.; Avasiloaiei, A.L.; Moscalu, M.; Zonda, G.I.; Stamatin, M. Total antioxidant 
status in fresh and stored human milk from mothers of term and preterm neonates. Pediatr. Neonatol. 2018, 
59, 600–605. 
20. Aycicek, A.; Erel, O.; Kocyigit, A.; Selek, S.; Demirkol, M.R. Breast milk provides better antioxidant power 
than does formula. Nutrition 2006, 22, 616–619. 
21. Oveisi, M.R.; Sadeghi, N.; Jannat, B.; Hajimahmoodi, M.; Behfar, A.O.; Jannat, F.; Mokhtarinasab, F. Human 
breast milk provides better antioxidant capacity than infant formula. Iran. J. Pharm. Res. 2010, 9, 445–449. 
Molecules 2020, 25, 2910 17 of 18 
 
22. Friel, J.K.; Martin, S.M.; Langdon, M.; Herzberg, G.R.; Buettner, G.R. Milk from mothers of both premature 
and full-term infants provides better antioxidant protection than does infant formula. Pediatr. Res. 2002, 51, 
612–618. 
23. Sandal, G.; Uras, N.; Gokmen, T.; Oguz, S.S.; Erdeve, O.; Dilmen, U. Assessment of oxidant/antioxidant 
system in newborns and their breast milks. J. Matern. Fetal Neonatal. Med. 2013, 26, 540–543. 
24. Hanson, C.; Lyden, E.; Furtado, J.; Ormer, M.V.; Anderson-Berry, A. A Comparison of Nutritional 
Antioxidant Content in Breast Milk, Donor Milk, and Infant Formulas. Nutrients 2016, 8, 681. 
25. Yuan, T.; Zhu, X.M.; Mu, G.; Qian, F.; Xiong, H. Effects of chemical composition and microstructure on 
lipid digestion in human milk and infant formulas. J. Agric. Food Chem. 2020, 68, 5462–5470. 
26. Joffre, C.; Dinel, A.L.; Chataigner, M.; Pallet, V.; Layé, S. n-3 Polyunsaturated Fatty Acids and Their 
Derivates Reduce Neuroinflammation during Aging. Nutrients 2020, 12, 647. 
27. Martinez, M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 
120, S129–S138. 
28. Grote, V.; Verduci, E.; Scaglioni, S.; Vecchi, F.; Contarini, G.; Giovannini, M.; Koletzko, B.; Agostoni, C. 
Breast milk composition and infant nutrient intakes during the first 12 months of life. European Childhood 
Obesity Project. Eur. J. Clin. Nutr. 2016, 70, 250–256. 
29. Bergner, E.M.; Shypailo, R.; Visuthranukul, C.; Hagan, J.; O’Donnell, A.R.; Hawthorne, K.M.; Abrams, S.A.; 
Hair, A.B. Growth, Body Composition, and Neurodevelopmental Outcomes at 2 Years Among Preterm 
Infants Fed an Exclusive Human Milk Diet in the Neonatal Intensive Care Unit: A Pilot Study. Breastfeed. 
Med. 2020, 15, 304–311. 
30. Lucas, A.; Boscardin, J.; Abrams, S.A. Preterm Infants Fed Cow’s Milk Derived Fortifier Had Adverse 
Outcomes Despite a Base Diet of Only Mother’s Own Milk. Breastfeed. Med. 2020, 15, 297–303. 
31. O’Connell, J.E.; Fox, P.F. Significance and applications of phenolic compounds in the production and 
quality of milk and dairy products: A review. Int. Dairy J. 2001, 11, 103–120. 
32. Karcz, K.; Królak-Olejnik, B. Vegan or vegetarian diet and breast milk composition—A systematic review. 
Crit. Rev. Food Sci. Nutr. 2020, 22, 1–18. 
33. Walstra, P.; Wouters, J.T.M.; Geurts, T.J. Dairy Science and Technology; Taylor & Francis: Boca Raton, FL, 
USA, 2006. 
34. Turhan, A.H.; Atici, A.; Muşlu, N. Antioxidant capacity of breast milk of mothers who delivered 
prematurely is higher than that of mothers who delivered at term. Int. J. Vitam. Nutr. Res. 2011, 81, 368–371. 
35. Salehi, B.; Martorell, M.; Arbiser, J.L.; Sureda A.; Martins, N.; Maurya, P.K.; Sharifi-Rad, M.; Kumar, P.; 
Sharifi-Rad, J. Antioxidants: Positive or Negative Actors? Biomolecules 2018, 8, 124. 
36. Czernichow, S.; Vergnaud, A.C.; Galan, P.; Arnaud, J.; Favier, A.; Faure, H.; Huxley, R.; Hercberg, S.; 
Ahluwalia, N. Effects of long-term antioxidant supplementation and association of serum antioxidant 
concentrations with risk of metabolic syndrome in adults. Am. J. Clin. Nutr. 2009, 90, 329–335. 
37. Rothman, K.J.; Moore, L.L.; Singer, M.R.; Nguyen, U.-S.D.; Mannino, S.; Milunsky, A. Teratogenicity of 
high vitamin A intake. N. Engl. J. Med. 1995, 333, 1369–1373. 
38. LeGal, K.; Ibrahim, M.X.; Wiel, C.; Sayin, V.I.; Akula, M.K.; Karlsson, C.; Dalin, M.G.; Akyürek, L.M.; 
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